Zentalis (ZNTL) 10% Owner Walters Group Buys 4.335M Shares

What Happened The Walters Group, a reported 10% owner of Zentalis Pharmaceuticals (ZNTL), purchased 4,335,000 shares of Zentalis common stock in an open-market/private purchase on August 14, 2026. The shares were acquired at $3.50 per share for a total transaction value of $15,172,500. This was a purchase (buy), which investors often view as a more informative/positive signal than routine selling.

Key Details

• Transaction date and price: 2026-08-14 — purchase of 4,335,000 shares at $3.50/share (total $15,172,500).
• Filing date: Form 4 filed 2026-08-19 (appears to be about 5 days after the transaction; the usual Form 4 deadline is within 2 business days).
• Shares owned after transaction: Not specified in this filing.
• Footnote: The shares are held directly by The Walters Group (TWG). William T. Walters and Susan B. Walters may be deemed to share voting and dispositive power over the shares; each disclaims beneficial ownership except to the extent of any pecuniary interest.
• Transaction code: P = Purchase.

Context

• This is an institutional/10% owner transaction, not an executive officer trade; such purchases reflect activity by a significant investor entity rather than day-to-day insider compensation or option exercises.
• No options exercised, awards, gifts, or tax-withholding noted in this filing.